$PED
PEDEVCO CORP Stock $ped

$ped Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000165495424010652 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$9.050M	$11.81M
YoY Change	23.47%	8.26%
Cost Of Revenue		$3.548M
YoY Change		26.31%
Gross Profit		$8.263M
YoY Change		2.0%
Gross Profit Margin		69.96%
Selling, General & Admin	$1.343M	$1.383M
YoY Change	3.55%	3.83%
% of Gross Profit		16.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$4.242M
YoY Change		31.13%
% of Gross Profit		51.34%
Operating Expenses	$6.954M	$9.173M
YoY Change	7.41%	24.36%
Operating Profit	$2.831M	$2.638M
YoY Change	230.72%	-25.35%
Interest Expense		$93.00K
YoY Change		8.14%
% of Operating Profit		3.53%
Other Income/Expense, Net	$84.00K	$43.00K
YoY Change	-9.68%	-50.0%
Pretax Income		$2.681M
YoY Change		-25.94%
Income Tax
% Of Pretax Income
Net Earnings	$2.915M	$2.681M
YoY Change	207.17%	-25.94%
Net Earnings / Revenue	32.21%	22.7%
Basic Earnings Per Share	$0.03	$0.03
Diluted Earnings Per Share	$0.03	$0.03
COMMON SHARES
Basic Shares Outstanding	89.29M shares	89.36M shares
Diluted Shares Outstanding	89.43M shares	89.33M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$6.132M
YoY Change		-50.8%
Cash & Equivalents	$4.619M	$6.132M
Short-Term Investments
Other Short-Term Assets		$135.0K
YoY Change		170.0%
Inventory
Prepaid Expenses
Receivables		$8.627M
Other Receivables		$172.0K
Total Short-Term Assets	$10.99M	$15.07M
YoY Change	-42.66%	-20.52%
LONG-TERM ASSETS
Property, Plant & Equipment		$92.03M
YoY Change		5.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.010M	$2.874M
YoY Change	-20.85%	-24.74%
Total Long-Term Assets	$103.3M	$95.92M
YoY Change	12.64%	5.62%
TOTAL ASSETS
Total Short-Term Assets	$10.99M	$15.07M
Total Long-Term Assets	$103.3M	$95.92M
Total Assets	$114.3M	$111.0M
YoY Change	3.09%	1.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.288M	$1.727M
YoY Change	22.2%	69.48%
Accrued Expenses	$2.160M	$1.581M
YoY Change	-8.24%	19.59%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.226M	$5.127M
YoY Change	-2.26%	25.91%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$2.703M
YoY Change		-4.35%
Total Long-Term Liabilities		$2.703M
YoY Change		-4.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.226M	$5.127M
Total Long-Term Liabilities		$2.703M
Total Liabilities	$7.773M	$7.830M
YoY Change	-9.54%	13.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$120.1M	-$123.0M
YoY Change	-1.92%	1.37%
Common Stock	$89.00K	$89.00K
YoY Change	2.3%	2.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$106.5M	$103.2M
YoY Change
Total Liabilities & Shareholders Equity	$114.3M	$111.0M
YoY Change	3.09%	1.1%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$2.915M	$2.681M
YoY Change	207.17%	-25.94%
Depreciation, Depletion And Amortization		$4.242M
YoY Change		31.13%
Cash From Operating Activities		$4.590M
YoY Change		-30.37%
INVESTING ACTIVITIES
Capital Expenditures		$11.41M
YoY Change		37.98%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities		-$11.41M
YoY Change		37.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities		4.590M
Cash From Investing Activities		-11.41M
Cash From Financing Activities
Net Change In Cash		-6.817M
YoY Change		306.99%
FREE CASH FLOW
Cash From Operating Activities		$4.590M
Capital Expenditures		$11.41M
Free Cash Flow		-$6.817M
YoY Change		306.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1332000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4242000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2898000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	9173000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	7060000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	3243000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	dei	Entity Central Index Key EntityCentralIndexKey	0001141197
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87250267	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89285267	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35922
	dei	Entity Registrant Name EntityRegistrantName	PEDEVCO CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-3755993
	dei	Entity Address Address Line1 EntityAddressAddressLine1	575 N. Dairy Ashford
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210
	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77079
	dei	City Area Code CityAreaCode	713
	dei	Local Phone Number LocalPhoneNumber	221-1768
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	PED
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	89285267	shares
CY2024Q2	us-gaap	Revenues Revenues	11811000	usd
CY2023Q2	us-gaap	Revenues Revenues	8548000	usd
	us-gaap	Revenues Revenues	19927000	usd
	us-gaap	Revenues Revenues	16712000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	3548000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	2830000	usd
	us-gaap	Lease Cost LeaseCost	6079000	usd
	us-gaap	Lease Cost LeaseCost	5296000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1383000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2878000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2820000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7727000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5479000	usd
	us-gaap	Operating Expenses OperatingExpenses	16684000	usd
	us-gaap	Operating Expenses OperatingExpenses	13595000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2638000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1488000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	3117000	usd
CY2024Q2	us-gaap	Interest Income Other InterestIncomeOther	93000	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	86000	usd
	us-gaap	Interest Income Other InterestIncomeOther	242000	usd
	us-gaap	Interest Income Other InterestIncomeOther	184000	usd
CY2024Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	12000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2024Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-50000	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-43000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	35000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	86000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	211000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	219000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	2681000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1574000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3454000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3336000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	89326805	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	87040267	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	89040322	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	86881427	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89326805	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87040267	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89040322	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86881427	shares
	ped	Disposition Of Escrow Cash Account DispositionOfEscrowCashAccount	-50000	usd
	ped	Disposition Of Escrow Cash Account DispositionOfEscrowCashAccount	0	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2837000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1628000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	0	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	98766000	usd
CY2024Q1	ped	Issuance Of Restricted Common Stock Amount IssuanceOfRestrictedCommonStockAmount	0	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	475000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	773000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	100014000	usd
CY2024Q2	ped	Rescinded Restricted Common Stock Amount RescindedRestrictedCommonStockAmount	0	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	462000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	2681000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	103157000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	96459000	usd
CY2023Q1	ped	Issuance Of Restricted Common Stock Amount IssuanceOfRestrictedCommonStockAmount	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	518000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1762000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	98739000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	517000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1574000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	100830000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11811000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8548000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19927000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16712000	usd
CY2024Q2	us-gaap	Cash Cash	6132000	usd
CY2023Q4	us-gaap	Cash Cash	18515000	usd
CY2024Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	2545000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	2200000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8677000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	20715000	usd
CY2023Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	185403000	usd
CY2024Q2	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	198490000	usd
CY2023Q4	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	12407000	usd
CY2024Q2	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	6543000	usd
CY2023Q4	ped	Asset Retirement Costs AssetRetirementCosts	853000	usd
CY2024Q2	ped	Asset Retirement Costs AssetRetirementCosts	998000	usd
CY2023Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	107070000	usd
CY2024Q2	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	114277000	usd
CY2023Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	91593000	usd
CY2024Q2	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	91754000	usd
	ped	Capital Costs Incurred Recently Completed Wells CapitalCostsIncurredRecentlyCompletedWells	6983000	usd
	ped	Description Of Additional Paid DescriptionOfAdditionalPaid	The Company also acquired approximately 407 net lease acres, in and around its existing footprint in the D-J Basin, through multiple transactions with total acquisition and due diligence costs of $240,000
CY2024Q2	us-gaap	Depletion Depletion	4042000	usd
CY2023Q2	us-gaap	Depletion Depletion	2690000	usd
	us-gaap	Depletion Depletion	7207000	usd
	us-gaap	Depletion Depletion	5137000	usd
CY2024Q2	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.100	pure
CY2024Q2	ped	Note In Current Assets NoteInCurrentAssets	172000	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	1022000	usd
CY2024Q2	ped	Accrued Interest AccruedInterest	71000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2313000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	499000	usd
	ped	Changes In Estimates ChangesInEstimates	145000	usd
CY2024Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2957000	usd
CY2023Q4	ped	Cureent Asset Retirement CureentAssetRetirement	147000	usd
CY2024Q2	ped	Cureent Asset Retirement CureentAssetRetirement	433000	usd
	us-gaap	Other Expenses OtherExpenses	10000	usd
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2027-02-28
	ped	Monthly Rent MonthlyRent	9200	usd
CY2024Q2	us-gaap	Security Deposit SecurityDeposit	14700	usd
CY2024Q2	us-gaap	Prepaid Rent PrepaidRent	14700	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	55000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	271000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	94000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	179000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	273000	usd
	ped	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P2Y8M12D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0790	pure
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	56000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	112000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	115000	usd
CY2024Q2	ped	Lessee Operating Lease Liability Payments Due Thereafter LesseeOperatingLeaseLiabilityPaymentsDueThereafter	19000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	302000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	29000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	273000	usd
	us-gaap	Other Commitments Description OtherCommitmentsDescription	In the D-J Basin, no net acres expire during the remainder of 2024, and 5,829 net acres expire within the next two-year period (net to our direct ownership interest only)
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2105000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	70000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	70000	shares
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	795000	usd
CY2024Q2	ped	Unamortized Stock Based Compensation Expense Restricted Stock Option UnamortizedStockBasedCompensationExpenseRestrictedStockOption	1409000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	460000	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.6775
CY2023Q1	us-gaap	Contract Termination Claims Description ContractTerminationClaimsDescription	The options have a term of five years and fully vest in January 2027, with 33.3% vesting each subsequent year from the date of grant, contingent upon the recipient’s continued service with the Company
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	216000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions	0.0404	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.04	pure
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	142000	usd
CY2024Q2	ped	Intrinsic Value Of Outstanding And Exercisable Options IntrinsicValueOfOutstandingAndExercisableOptions	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1632334	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.28
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y9M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	460000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.68
	ped	Share Based Compensation Arrangement By Share Based Payment Award Options Canceled In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod	-256667	shares
	ped	Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice	1.30
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1835667	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.12
	ped	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a	P2Y10M24D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	935667	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.35
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P1Y10M24D
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	2681000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1574000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3454000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3336000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89326805	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87040267	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89040322	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86881427	shares
CY2024Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89326805	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87040267	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89040322	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86881427	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q2	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1835667	shares
CY2023Q2	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1926001	shares
	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1835667	shares
	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1926001	shares

Files In Submission

Name	View Source	Status
0001654954-24-010652-index-headers.html	Edgar Link	pending
0001654954-24-010652-index.html	Edgar Link	pending
0001654954-24-010652.txt	Edgar Link	pending
0001654954-24-010652-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ped-20240630.xsd	Edgar Link	pending
ped_10q.htm	Edgar Link	pending
ped_10qimg1.jpg	Edgar Link	pending
ped_ex311.htm	Edgar Link	pending
ped_ex312.htm	Edgar Link	pending
ped_ex321.htm	Edgar Link	pending
ped_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
ped-20240630_cal.xml	Edgar Link	unprocessable
ped-20240630_def.xml	Edgar Link	unprocessable
ped-20240630_lab.xml	Edgar Link	unprocessable
ped-20240630_pre.xml	Edgar Link	unprocessable
ped_10q_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PED
PEDEVCO CORP Stock $ped

2024 Q3 Form 10-Q Financial Statement

#000165495424010652 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PED PEDEVCO CORP Stock $ped

2024 Q3 Form 10-Q Financial Statement

#000165495424010652 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PED
PEDEVCO CORP Stock $ped